MedPath

Trial of acute femoral fracture fixatio

Not Applicable
Completed
Conditions
Fragility fractures of the distal femur
Musculoskeletal Diseases
Registration Number
ISRCTN92089567
Lead Sponsor
niversity of Oxford
Brief Summary

2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29137679 protocol 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31549959 results (added 27/09/2019) 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31061043/ results (added 04/06/2020) 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/31371167/ feasibility results (added 14/06/2023) 2019 Results article in https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3597-8 mixed methods process evaluation (added 14/06/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
23
Inclusion Criteria

1. Patients of 18 years old and above
2. Present to participating hospitals with a fracture of the distal femur (i.e. involving the distal 2 Muller squares)
3. Attending surgeon feels that the patient will benefit from internal fixation of the fracture

Exclusion Criteria

1. Patients who have a knee or hip arthroplasty that requires revision
2. A pre-existing arthroplasty that precludes fixation with an intramedullary nail
3. Patients with pre-existing femoral deformity will also be excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Recruitment rate, calculated throughout the study and determined as the number of eligible participants who gave consent to participate<br>2. Completion rate of the EQ-5D-5L is measured 4 months post injury
Secondary Outcome Measures
NameTimeMethod
1. Demential Quality of Life questionnaire (DEMQoL) at baseline, 6-weeks post injury, and 4-months post-injury<br>2. Disability rating index (DRI) at baseline, 6-weeks post injury, and 4-months post-injury<br>3. Mixed methods analysis of a process evaluation, including patient and staff interviews throughout the length of the trial
© Copyright 2025. All Rights Reserved by MedPath